Skip to main content
The Society of Thoracic Surgeons

User account menu

  • Log in
Menu

Main navigation

  • FIGHT
    • Coping with Cancer
      • Just Diagnosed
      • In Treatment
      • In Remission
      • Survivorship
    • Cancer Information
      • Bladder Cancer
      • Blood Cancer
      • Breast Cancer
      • Head and Neck Cancer
      • Lung Cancer
      • Melanoma
      • Other
      • Latest Featured Content
      • The Archives
      • Other Resources
    • Find Clinical Trials
    • Glossary
      • Cancer FAQs
  • EDUCATE
    • Current Patient Education Video Series
      • ASCO Lung Roundtable
      • Bladder Cancer Video Library
      • Cancer Information for the Latino Community
      • Case Based Panel Discussions
      • Clinical Trials Experiences Through Storytelling
      • Coronavirus and Covid 19 in the Cancer Community
      • East Asian Lung Cancer Video Library
      • HPV Advances - A Patient Education Program
      • Head and Neck Cancer News and Updates ASCO / ESMO
      • Lung Cancer Video Library - English
      • Lung Cancer Video Library - Spanish
      • Lung OncTalk
      • Patient Education Ambassador Program
      • Targeted Therapies Patient Forum - English
      • Targeted Therapies Patient Forum - Spanish
      • Testing and Early Diagnosis
    • GRACE Podcasts
    • Video Library
      • English
      • Spanish
      • Mandarin
  • PARTICIPATE
    • Community Forum
      • Bladder Cancer
      • Blood Cancer
      • Brain Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Gall Bladder and Bile Duct Cancer (Cholangiocarcinoma)
      • Head and Neck Cancer
      • Kidney Cancer
      • Lung Cancer
      • Melanoma
      • Member Updates
      • General Forums
      • Ask A Question
    • Get Involved
      • Memorials and Tributes
      • Volunteer Opportunities
  • ABOUT CancerGRACE
    • GRACE NEWS AND INFO
      • Contact Us
      • How (and Why) to Use GRACE
      • GRACE Public Disclosure Documentation
    • About GRACE
      • Mission
      • Opportunities
      • Terms of Use
      • Our Supporters 2020
    • Our Team
      • Faculty
      • Staff and Board
    • Partnerships
      • GRACE and Clinical Care Options Patient Tools
      • Varian Partner Page 2020
      • Takeda Oncology Partnership Page 2020
      • Lilly Oncology Partner Page
  • DONATE
    • Why Give to GRACE
      • More Ways to Give
      • Corporate Giving Programs
      • Gifts of Stock or Securities
      • Shop and Search for the Cause
      • Create a Tribute
      • Create Your Own Fundraiser
      • Shop with GRACE

Breadcrumb

  1. Home
  2. Forums
  3. HYPO 5 fractions at 600 rad better option than HYPER 30 fractions at 200 rad? - 1293560

Stage 4 NSCLC-Adenocarcinoma maintenance choices

Forums
General NSCLC

History- Diagnosis in February, metastasis to thyroid, lymph nodes, chest wall. Malignant pleural effusion-had pleurex cathether which was recently removed due to little fluid. Pdl1 40%, KRAS mutation

  • Read more about Stage 4 NSCLC-Adenocarcinoma maintenance choices
  • 5 comments
  • Log in or register to post comments

What is the Value of Testing for Molecular Markers in Advanced NSCLC?

Article

Memorial Sloan-Kettering Cancer Center medical oncologist Dr. Greg Riely explains how testing for specific mutations in patients with advanced NSCLC can guide prognosis and treatment recommendations.

  • Read more about What is the Value of Testing for Molecular Markers in Advanced NSCLC?

Immunotherapy for Lung Cancer: Currently Enrolling Clinical Trials of Combination Therapies

Article

Immunotherapy Forum Video #25: In Part 2 of 2 videos, Dr.

  • Read more about Immunotherapy for Lung Cancer: Currently Enrolling Clinical Trials of Combination Therapies

Targeting the RAF Pathway in Lung Cancer

Article

Dr. Charles Rudin of Memorial Sloan Kettering talks about RAF and other genetic mutations that play a role in the growth of lung cancer. February 2014.

[powerpress]

  • Read more about Targeting the RAF Pathway in Lung Cancer
  • 4 comments

Squamous Lung Cancer Part 5, Q and A Session by Dr. David Spigel

Article

Title slide from Squamous Lung Cancer Webinar Q&A SessionDr. David Spigel, Sarah Cannon Cancer Center, answers audience questions about squamous lung cancer.

 

[powerpress]

  • Read more about Squamous Lung Cancer Part 5, Q and A Session by Dr. David Spigel

Squamous Lung Cancer, Part 2: Genomic Testing by Dr. David Spigel

Article

Chart and graph representing genetic mutations across 12 different cancer typesDr. David Spigel, Sarah Cannon Cancer Center, discusses the importance of genomic testing in squamous lung cancer.

 

[powerpress]

  • Read more about Squamous Lung Cancer, Part 2: Genomic Testing by Dr. David Spigel
  • 1 comment

Can we target KRAS effectively in advanced NSCLC?

Article

Drs. Mary Pinder, Nate Pennell, and Jack West discuss developments with selumetinib and other MEK inhibitors as a potential target for the 20-25% of NSCLC patients with a KRAS mutation.

[powerpress]

Discuss this post in the GRACE Discussion Forums

  • Read more about Can we target KRAS effectively in advanced NSCLC?

Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?

Article

Dr. David Spigel from Sarah Cannon Cancer Center offers his perspective on the agents he feels most likely to become clinical tools against lung cancer over the next few years.

[powerpress]

  • Read more about Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?

New Publication Highlights Hope for NSCLC Patients with KRAS Mutation

Article

Here's a recent video podcast I just did on the publication just out in Lancet Oncology, describing a randomized phase II study led by my friend Pasi Janne, from Dana Farber Cancer Institute in Boston.

[powerpress]

  • Read more about New Publication Highlights Hope for NSCLC Patients with KRAS Mutation

Is there a new, promising option for people with the most common mutation seen in lung cancer?

Article

The report of the phase II randomized trial of MEK inhibitor selumetinib for KRAS mutation-positive NSCLC was just published in Lancet Oncology.  Here's my discussion of some of the highlights of this work and what this means.

[powerpress]

  • Read more about Is there a new, promising option for people with the most common mutation seen in lung cancer?

Pagination

  • Page 1
  • Next page ››
Subscribe to KRAS

Stay In touch

NEWSLETTER SIGN UP

MISSIONDONATEDISCLAIMERRESOURCES

Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock

  • Log in
  • FIGHT
    • Coping with Cancer
      • Just Diagnosed
      • In Treatment
      • In Remission
      • Survivorship
    • Cancer Information
      • Bladder Cancer
      • Blood Cancer
        • Blood Cancer Video Library 2021
      • Breast Cancer
      • Head and Neck Cancer
      • Lung Cancer
      • Melanoma
      • Other
      • Latest Featured Content
      • The Archives
      • Other Resources
    • Find Clinical Trials
    • Glossary
      • Cancer FAQs
  • EDUCATE
    • Current Patient Education Video Series
      • ASCO Lung Roundtable
      • Bladder Cancer Video Library
      • Cancer Information for the Latino Community
      • Case Based Panel Discussions
      • Clinical Trials Experiences Through Storytelling
      • Coronavirus and Covid 19 in the Cancer Community
      • East Asian Lung Cancer Video Library
      • HPV Advances - A Patient Education Program
      • Head and Neck Cancer News and Updates ASCO / ESMO
      • Lung Cancer Video Library - English
      • Lung Cancer Video Library - Spanish
      • Lung OncTalk
      • Patient Education Ambassador Program
      • Targeted Therapies Patient Forum - English
      • Targeted Therapies Patient Forum - Spanish
      • Testing and Early Diagnosis
    • GRACE Podcasts
    • Video Library
      • English
      • Spanish
      • Mandarin
  • PARTICIPATE
    • Community Forum
      • Bladder Cancer
      • Blood Cancer
      • Brain Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Gall Bladder and Bile Duct Cancer (Cholangiocarcinoma)
      • Head and Neck Cancer
      • Kidney Cancer
      • Lung Cancer
      • Melanoma
      • Member Updates
      • General Forums
      • Ask A Question
    • Get Involved
      • Memorials and Tributes
      • Volunteer Opportunities
  • ABOUT CancerGRACE
    • GRACE NEWS AND INFO
      • Contact Us
      • How (and Why) to Use GRACE
      • GRACE Public Disclosure Documentation
    • About GRACE
      • Mission
      • Opportunities
      • Terms of Use
      • Our Supporters 2020
    • Our Team
      • Faculty
      • Staff and Board
    • Partnerships
      • GRACE and Clinical Care Options Patient Tools
      • Varian Partner Page 2020
      • Takeda Oncology Partnership Page 2020
      • Lilly Oncology Partner Page
  • DONATE
    • Why Give to GRACE
      • More Ways to Give
      • Corporate Giving Programs
      • Gifts of Stock or Securities
      • Shop and Search for the Cause
      • Create a Tribute
      • Create Your Own Fundraiser
      • Shop with GRACE